Extended release felodipine self-nanoemulsifying system

AAPS PharmSciTech

Volumn 10, Issue 2, 2009, Pages 515-523

  Patil, Pradeep R ^a   Biradar, Shailesh V ^a   Paradkar, Anant R ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

Extended release; Felodipine; Gelucire 43 01; Self nanoemulsifying system

Indexed keywords

AEROSIL; CAPROL; CREMOPHOR; FELODIPINE; GELUCIRE; MIGLYOL; OCTANOIN; UNCLASSIFIED DRUG; CALCIUM CHANNEL BLOCKING AGENT; NANOPARTICLE;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ELASTICITY; EMULSION; HYDROPHOBICITY; IN VITRO STUDY; NANOEMULSION; TURBIDITY; CHEMISTRY; DELAYED RELEASE FORMULATION; SOLUBILITY; VISCOSITY;

CALCIUM CHANNEL BLOCKERS; CALORIMETRY, DIFFERENTIAL SCANNING; DELAYED-ACTION PREPARATIONS; EMULSIONS; FELODIPINE; NANOPARTICLES; SOLUBILITY; VISCOSITY;

EID: 67549127535     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9235-0     Document Type: Article

References (36)

1. Charman SA, Charman WN, Rogge MC, Wilson TD, Pouton CW. Self-emulsifying drug delivery systems: Formulation and biopharmaceutical evaluation of an investigational lipophilic compound. Pharm Res. 1992;9:87-93.
2. Pouton CW. Self-emulsifying drug delivery systems: Assessment of the efficiency of emulsification. Int J Pharm. 1985;27:335-48.
3. Shah NH, Carvajal MT, Patel CI, Infeld NH, Malick AW. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm. 1994;106:15-23.
4. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173-82.
5. Hansen T, Holm P, Schultz K. Process characteristics and compaction of spray-dried emulsions containing a drug in lipids. Int J Pharm. 2004;287:55-66.
6. Kim CK, Shin HJ, Yang SG, Kim JH, Oh YK. Once-a-day oral dosing regimen of cyclosporin A: Combined therapy of cyclosporin a premicroemulsion concentrates and enteric-coated solid-state premicroemulsion concentrates. Pharm Res. 2001;18:454-59.
7. Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. Optimization of self-nanoemulsified tablet dosage form of ubiquinone using response surface methodology: Effect of formulation ingredients. Int J Pharm. 2002;240:103-14.
8. Gao P, Rush BD, Pfund WP, Huang T, Bauer JM, Morozowich W, et al. Development of supersaturable SEDDS formulation of paclitaxel with improved oral bioavailability. J Pharm Sci. 2003;92:2386-98.
9. Newton M, Petersson J, Podczeck F, Clarke A, Booth S. The influence of formulation variables on the properties of pellets containing a self-emulsifying mixture. J Pharm Sci. 2001;90:987-95.
10. Tuleu C, Newton M, Rose J, Euler D, Saklatvala R, Clarke A, et al. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension. J Pharm Sci. 2004;93:1495-502.
11. Attama AA, Nzekwe IT, Nnamani PO, Adikwu MU, Onugu CO. The use of solid self-emulsifying systems in the delivery of diclofenac. Int J Pharm. 2003;262:23-8.
12. Booth SW, Clarke A, Newton JM. Spheronized self-emulsifying system for hydrophobic and water sensitive agents. United States Patent number 6,630,150, 2003.
13. Patil P, Joshi P, Paradkar A. Effect of formulation variables on preparation and evaluation of gelled self-emulsifying drug delivery system (SEDDS) of ketoprofen. AAPS PharmSciTech. 2004;5:E 42.
14. Barthelemy P, Benameur H. Composition with sustained release of active principle, capable of forming microemulsion. United States Patent number 6,309,665 (2001).
15. Schwarz J. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process of preparation thereof. United States Patent Application Publication number 20030072798 (2003).
16. Serratoni M, Newton M, Booth S, Clarke A. Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. Eur J Pharm Biopharm. 2007;65:94-8.
17. Sutananta W, Craig DQM, Newton JM. The effects of ageing and thermal behavior and mechanical properties of pharmaceutical glycerides. Int J Pharm. 1994;111:51-62.
18. Ainaoui A, Ouriemchi EM, Bidah D, El Amrani MK, Vergnaud JM. Process of drug release with oral dosage forms with lipidic gelucire matrix. J Polym Eng. 1997;17:245-57.
19. Ainaoui A, Vergnaud JM. Modeling the plasma drug level with oral controlled release forms with lipidic Gelucire. Int J Pharm. 1998;169:155-62.
20. Dennis AB, Farr SJ, Kellaway IW, Taylor G, Davidson R. In vivo evaluation of rapid release and sustained release gelucire capsule formulations. Int J Pharm. 1990;65:85-100.
21. Barker SA, Yap SP, Yeun KH, McCoy CP, Murphy JR, Craig DQM. An investigation into the structure and bioavailability of alpha tocopherol dispersion in gelucire 44/14. J Control Release. 2003;91:477-88.
22. Sutananta W, Craig DQM, Newton JM. An evaluation of mechanisms of drug release from glycerides bases. J Pharm Pharmacol. 1995;47:182-7.
23. Trojak A, Kocevar K, Musevic I, Srcic S. Investigation of the felodipine glassy state by atomic force microscopy. Int J Pharm. 2001;218:145-51.
24. Sharma VK. Preparation of micron-size pharmaceutical particles by micro-fluidization. United States Patent number 6,555,139, 2003.
25. Won DH, Kim MS, Lee S, Park JS, Hwang SJ. Improved physicochemical characteristics of felodipine solid dispersion particles by supercritical anti-solvent precipitation process. Int J Pharm. 2005;301:199-208.
26. Karavas E, Georgarakis E, Bikiaris D. Felodipine nanodispersions as active core for predictable pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. Int J Pharm. 2006;313:189-97.
27. Pannarale G, Puddu PE, Monti F, Collauto F, Serafini G, Schiariti M, et al. 24-hour antihypertensive efficacy of extended release felodipine. Am J Hypertens. 1995;8:73A.
28. Eklund M, Lofroth J, Sundgren M. New pharmaceutical formulation. Patent Cooperation Treaty Application Publication number WO/2001/005376 (2001).
29. Raghavan SR, Walls HJ, Khan SA. Rheology of silica dispersions in organic liquids: New evidence for salvation forces dictated by hydrogen bonding. Langmuir 2000;16:7920-30.
30. Barnes HA, Hutton JF, Walters K. An introduction to rheology. In: Rheology Series, Elsevier, Amsterdam, 1989.
31. Eccleston GM, Barry BW, Davis SS. Correlation of viscoelastic functions for pharmaceutical semisolids: Comparison of creep and oscillatory tests for oil-in-water creams stabilized by mixed emulsifiers. J Pharm Sci. 1973;62:1954-61.
32. Kobayashi M, Ishikawa S, Samejima M. Application of nonlinear viscoelastic analysis by the oscillation method to some pharmaceutical ointments in the Japanese Pharmacopeia. Chem Pharm Bull. 1982;30:4468-78.
33. Davis SS. Viscoelastic properties of pharmaceutical semisolids III: nondestructive oscillatory testing. J Pharm Sci. 1971;60:1351-5.
34. Korsmeyer RW, Gurny R, Doelker EM, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm. 1983;15:25-35.
35. Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13:123-33.
36. Abdalla A, Mader K. Preparation and characterization of a self-emulsifying pellet formulation. Eur J Pharm Biopharm. 2007;66:220-6.